Correlation Between VectivBio Holding and Akari Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both VectivBio Holding and Akari Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VectivBio Holding and Akari Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between VectivBio Holding AG and Akari Therapeutics PLC, you can compare the effects of market volatilities on VectivBio Holding and Akari Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VectivBio Holding with a short position of Akari Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of VectivBio Holding and Akari Therapeutics.

Diversification Opportunities for VectivBio Holding and Akari Therapeutics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between VectivBio and Akari is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding VectivBio Holding AG and Akari Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akari Therapeutics PLC and VectivBio Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VectivBio Holding AG are associated (or correlated) with Akari Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akari Therapeutics PLC has no effect on the direction of VectivBio Holding i.e., VectivBio Holding and Akari Therapeutics go up and down completely randomly.

Pair Corralation between VectivBio Holding and Akari Therapeutics

If you would invest  100.00  in Akari Therapeutics PLC on December 29, 2024 and sell it today you would earn a total of  30.00  from holding Akari Therapeutics PLC or generate 30.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

VectivBio Holding AG  vs.  Akari Therapeutics PLC

 Performance 
       Timeline  
VectivBio Holding 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days VectivBio Holding AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, VectivBio Holding is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.
Akari Therapeutics PLC 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Akari Therapeutics PLC are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Akari Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

VectivBio Holding and Akari Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with VectivBio Holding and Akari Therapeutics

The main advantage of trading using opposite VectivBio Holding and Akari Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VectivBio Holding position performs unexpectedly, Akari Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akari Therapeutics will offset losses from the drop in Akari Therapeutics' long position.
The idea behind VectivBio Holding AG and Akari Therapeutics PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format